INDUCTION OF C-FOS, JUN-B AND EGR-1 EXPRESSION BY HALOPERIDOL IN PC12 CELLS - INVOLVEMENT OF CALCIUM

被引:9
作者
ESTEVE, L
HABY, C
RODEAU, JL
HUMBLOT, N
AUNIS, D
ZWILLER, J
机构
[1] CTR NEUROCHIM,INSERM,U338,F-67084 STRASBOURG,FRANCE
[2] CNRS,CTR NEUROCHIM,NEUROBIOL CELLULAIRE LAB,STRASBOURG,FRANCE
关键词
FOS; JUN; IMMEDIATE EARLY GENE; CYTOSOLIC FREE CA2+; PC12; CELLS;
D O I
10.1016/0028-3908(95)00006-R
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Acute injection of haloperidol, a dopamine D2 receptor antagonist, is known to increase immediate early gene expression of the fos and jun families in rodent striatal neurons. A set of gene induction, including c-fas,jun B and TIS8/egr-1, was found when haloperidol was added to PC12 cells in culture. Electrophoretic mobility-shift assays show that haloperidol-evoked gene induction was accompanied by a transient and dose-dependent increase in AP1 and EGR-1 binding activities in these cells. Gene expression is tentatively explained by the rapid and transient increase in cytosolic free Ca2+ concentration observed upon haloperidol addition. The cytosolic calcium rise and AP1 binding activation elicited by haloperidol were dependent on extracellular Ca2+, suggesting that haloperidol exerted its effects by promoting Ca2+ entry into PC12 cells. The haloperidol-induced increase in API binding activity and intracellular Ca2+ was not reproduced by two other dopamine D2 receptor antagonists, sulpiride and (+)-butaclamol.
引用
收藏
页码:439 / 448
页数:10
相关论文
共 39 条
[1]   DOPAMINE RECEPTOR SUBTYPES - BEYOND THE D1/D2 CLASSIFICATION [J].
ANDERSEN, PH ;
GINGRICH, JA ;
BATES, MD ;
DEARRY, A ;
FALARDEAU, P ;
SENOGLES, SE ;
CARON, MG .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (06) :231-236
[2]   A RAPID MICROPREPARATION TECHNIQUE FOR EXTRACTION OF DNA-BINDING PROTEINS FROM LIMITING NUMBERS OF MAMMALIAN-CELLS [J].
ANDREWS, NC ;
FALLER, DV .
NUCLEIC ACIDS RESEARCH, 1991, 19 (09) :2499-2499
[3]   HALOPERIDOL AND LOXAPINE BUT NOT CLOZAPINE INCREASE SYNAPTIC RESPONSES IN THE HIPPOCAMPUS [J].
BASKYS, A ;
WANG, S ;
REMINGTON, G ;
WOJTOWICZ, JM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 235 (2-3) :305-307
[4]   DOPAMINE-RECEPTORS ON ADRENAL CHROMAFFIN CELLS MODULATE CALCIUM-UPTAKE AND CATECHOLAMINE RELEASE [J].
BIGORNIA, L ;
SUOZZO, M ;
RYAN, KA ;
NAPP, D ;
SCHNEIDER, AS .
JOURNAL OF NEUROCHEMISTRY, 1988, 51 (04) :999-1006
[5]   VOLTAGE-DEPENDENT TRANSIENT CALCIUM CURRENTS IN FRESHLY DISSOCIATED CAPILLARY ENDOTHELIAL-CELLS [J].
BOSSU, JL ;
FELTZ, A ;
RODEAU, JL ;
TANZI, F .
FEBS LETTERS, 1989, 255 (02) :377-380
[6]   CHANGES IN DOPAMINE-D1, DOPAMINE-D2 AND DOPAMINE-D3 RECEPTOR MESSENGER-RNA LEVELS IN RAT-BRAIN FOLLOWING ANTIPSYCHOTIC TREATMENT [J].
BUCKLAND, PR ;
ODONOVAN, MC ;
MCGUFFIN, P .
PSYCHOPHARMACOLOGY, 1992, 106 (04) :479-483
[7]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[8]   DOPAMINERGIC REGULATION OF DOPAMINE RELEASE FROM PC12 CELLS VIA A PERTUSSIS TOXIN-SENSITIVE G-PROTEIN [J].
COURTNEY, ND ;
HOWLETT, AC ;
WESTFALL, TC .
NEUROSCIENCE LETTERS, 1991, 122 (02) :261-264
[9]  
DEKEYSER J, 1993, NEUROCHEM INT, V22, P83
[10]   D2 DOPAMINE RECEPTOR ANTAGONISTS INDUCE FOS AND RELATED PROTEINS IN RAT STRIATAL NEURONS [J].
DRAGUNOW, M ;
ROBERTSON, GS ;
FAULL, RLM ;
ROBERTSON, HA ;
JANSEN, K .
NEUROSCIENCE, 1990, 37 (02) :287-294